Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (131-140 of 244) with videos related to

Pageof 25
Sort By:
BMJ Open|August 22, 2023
Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysisMaya Thomas, Sanjana Murali, Benjamin Scott S Simpson, et al.
European Radiology|November 21, 2018
Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancerNikolaos Dikaios, Francesco Giganti, Harbir S Sidhu, et al.
The British Journal of Radiology|December 1, 2017
Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRIMrishta Brizmohun Appayya, Harbir S Sidhu, Nikolaos Dikaios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinomaOliver J Kayes, Marco Loddo, Nimish Patel, et al.
The Journal of Urology|July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
The Lancet. Oncology|April 20, 2012
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyHashim U Ahmed, Richard G Hindley, Louise Dickinson, et al.
Urology|December 5, 2020
Prostate Cancer Undetected by mpMRI: Tumor Conspicuity is Reliant Upon Optimal Scan Timing and QualityJoseph M Norris, Clare Allen, Rhys Ball, et al.
Journal of Robotic Surgery|April 13, 2022
Diagnostic potential of radiological apical tumor involvementCasril Liebert, Naomi Morka, Pranav Satish, et al.
Skin Health and Disease|August 6, 2024
Primary vulval melanoma and genital lichen sclerosusEvanthia Mastoraki, Georgios Kravvas, Kate Dear, et al.
Radiology|March 28, 2013
Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndromeRola S Nakhal, Margaret Hall-Craggs, Alex Freeman, et al.
Pageof 25

Showing results (131-140 of 244) with videos related to

Sort By:
Pageof 25
BMJ Open|August 22, 2023
Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysisMaya Thomas, Sanjana Murali, Benjamin Scott S Simpson, et al.
European Radiology|November 21, 2018
Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancerNikolaos Dikaios, Francesco Giganti, Harbir S Sidhu, et al.
The British Journal of Radiology|December 1, 2017
Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRIMrishta Brizmohun Appayya, Harbir S Sidhu, Nikolaos Dikaios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinomaOliver J Kayes, Marco Loddo, Nimish Patel, et al.
The Journal of Urology|July 24, 2020
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis <i>J Urol</i> 2020; doi: 10.1097/JU.0000000000001157Vasilis Stavrinides, Francesco Giganti, Shonit Punwani, et al.
The Lancet. Oncology|April 20, 2012
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyHashim U Ahmed, Richard G Hindley, Louise Dickinson, et al.
Urology|December 5, 2020
Prostate Cancer Undetected by mpMRI: Tumor Conspicuity is Reliant Upon Optimal Scan Timing and QualityJoseph M Norris, Clare Allen, Rhys Ball, et al.
Journal of Robotic Surgery|April 13, 2022
Diagnostic potential of radiological apical tumor involvementCasril Liebert, Naomi Morka, Pranav Satish, et al.
Skin Health and Disease|August 6, 2024
Primary vulval melanoma and genital lichen sclerosusEvanthia Mastoraki, Georgios Kravvas, Kate Dear, et al.
Radiology|March 28, 2013
Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndromeRola S Nakhal, Margaret Hall-Craggs, Alex Freeman, et al.
Pageof 25